Journal for ImmunoTherapy of Cancer (Nov 2023)

301 Preclinical development of AB-2100, a PSMA neovasculature-inducible CA9 CAR resistant to FASL and TGFb mediated suppression for the treatment of ccRCC

  • Ivan Chan,
  • Laura Lim,
  • Irene Scarfò,
  • Darrian Moskowitz,
  • Beatriz Millare,
  • Kevin Dang,
  • Jeremy Chen,
  • Nickolas Attanasio,
  • Angela Boroughs,
  • Michelle Nguyen,
  • Suchismita Mohanty,
  • Jenessa Smith,
  • James Zhang,
  • Jennifer McDevitt,
  • Thomas J Gardner,
  • Alma Gomez,
  • Vince Thomas,
  • Marvin Chew,
  • Rakesh Sudhakah,
  • Amanda Fearon,
  • Vibhavari Sail,
  • Stanley Zhou

DOI
https://doi.org/10.1136/jitc-2023-SITC2023.0301
Journal volume & issue
Vol. 11, no. Suppl 1

Abstract

Read online

No abstracts available.